Ghio Lucio, Puppo Serena, Presta Andrea
IRCCS University Hospital San Martino – IST, Genoa, Italy.
Curr Drug Saf. 2012 Nov 1;7(5):389-90. doi: 10.2174/157488612805076589.
In the past 10 years there has been an emphasis on the risk of upper gastrointestinal bleeding in patients taking SSRI antidepressants. Few studies have concurrently examined the possible risk of traditional antidepressants or atypical antidepressants such as venlafaxine, classified as a serotonin-norepinephrine reuptake inhibitor. In order to promote debate about possible risk of upper gastrointestinal bleeding in elderly patients taking antidepressants different from SSRIs, we report a case of venlafaxine-induced upper gastrointestinal bleeding in a 84 years old woman. Discussion about safer drugs and protective factors is provided.
在过去10年里,一直强调服用选择性5-羟色胺再摄取抑制剂(SSRI)类抗抑郁药的患者发生上消化道出血的风险。很少有研究同时考察传统抗抑郁药或非典型抗抑郁药(如被归类为5-羟色胺-去甲肾上腺素再摄取抑制剂的文拉法辛)可能存在的风险。为了推动关于服用不同于SSRI类抗抑郁药的老年患者发生上消化道出血潜在风险的讨论,我们报告了1例84岁女性因服用文拉法辛导致上消化道出血的病例。并提供了关于更安全药物和保护因素的讨论。